Snehal Patel, Global Head of Cell Therapy Manufacturing at Bristol Myers Squibb, stand outside the facility on Monday in Bothell. (Andy Bronson / The Herald)

Snehal Patel, Global Head of Cell Therapy Manufacturing at Bristol Myers Squibb, stand outside the facility on Monday in Bothell. (Andy Bronson / The Herald)

Purchase Photo

Cancer patients nationwide send their blood cells to Bothell

At a Bristol Myers Squibb lab, the cells are altered and returned to patients fighting non-Hodgkin’s lymphoma.

BOTHELL — It might look like an ordinary manufacturing center from the parking lot, but this “factory” is busy producing cancer-fighting cells.

A Bristol Myers Squibb “therapy manufacturing center” in Bothell is ramping up production of a new blood-cancer treatment after it received federal approval earlier this year.

On Feb. 5, the U.S. Food and Drug Administration approved Breyanzi, a cell-based genetic therapy, for commercial use. A one-time infusion, it treats patients with non-Hodgkin’s lymphoma when at least two treatments haven’t worked or have stopped working.

Breyanzi involves re-engineering and revving up a patient’s own immune cells to detect, attack and kill cancer cells.

The 68,000-square-foot Bothell site is equipped to modify T-cells, said Snehal Patel, vice president and global head of cell therapy manufacturing.

Non-Hodgkin’s lymphoma is a cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system. The disorder weakens the immune system and its ability to fight infection. In the U.S., it accounts for about 4% of all cancers. The American Cancer Society estimates that nearly 82,000 people this year will be diagnosed with the non-Hodgkin’s lymphoma.

The personalized therapy begins at one of 40 treatment centers, where a patient’s T-cells, a type of white blood cell, are collected.

The cells are then carefully preserved and shipped to the Bothell site, which serves patients throughout the U.S., Patel said.

At the facility, the cells are genetically altered to locate and destroy cancer cells.

A viral vector — a virus that’s been modified so that it can’t replicate — is used to deliver genetic material to the T-cell. Once it reaches the target, it makes changes to the cell, enabling it to identify and destroy cancer cells. A few weeks later, the enhanced T-cells are returned to the patient in the form of a one-time infusion. Patients are then monitored for several weeks, staying close to the treatment center.

“Breyanzi has deep Pacific Northwest roots from being developed by local scientific teams,” said Ann Lee, senior vice president and head of cell therapy development and operations at Bristol Myers.

Juno Therapeutics, a Bothell biotech firm, began the process in 2013, collaborating with the Fred Hutchinson Cancer Research Center in Seattle, Seattle Children’s Research Institute and Memorial Sloan-Kettering Cancer Center in New York.

Juno was purchased by Celgene Corp in 2018 for $9 billion. A year later, Bristol Myers Squibb acquired Celgene in a $74 billion deal.

The Bristol Meyers Squibb manufacturing center and a separate Canyon Park Business Park location currently employ about 550 people, but the company plans to expand its footprint with the addition of a 44,000-square-foot business center to support employees and enable further manufacturing expansion.

“Travis Lynn and Rian Zeigler — two of our guys — are helping design the new business center,” said Patel, describing it as a “significant investment.”

“We’re proud to invest in the Bothell area,” Patel said “We have employees from Everett, Mill Creek, Monroe and Snohomish. We’ve also recently hired some Boeing folks, giving them the chance to enter the health care space.”

Bristol Myers recently partnered with Shoreline Community College to develop a biotech certification program that prepares students for entry-level laboratory work, Patel said.

Breyanzi is the first of two Bristol Myers cell therapy treatments to receive FDA approval this year for commercial distribution.

In March, the FDA approved Abecma for multiple myeloma, a rare blood cancer that blocks bone marrow from making enough healthy blood cells. The disorder can result in low blood counts that weaken the immune system and damage the bones and kidneys.

Abecma was developed by Celgene and a Boston-based biotech, bluebird bio. It will be produced at a Bristol Myers cell therapy manufacturing site in New Jersey.

Janice Podsada; jpodsada@heraldnet.com; 425-339-3097; Twitter: JanicePods

Talk to us

More in Herald Business Journal

Signs from the Department of Ecology warning about contamination in the creek that runs through Powder Mill Gulch on Wednesday, March 31, 2021 in Everett, Wa. (Olivia Vanni / The Herald)
State order targets Boeing Everett plant’s polluted history

Records show a dispute over cleanup requirements for chemically tainted water. The company denies there’s a disagreement.

Project Roxy is a proposed 2.8 million square foot distribution center that would be built on a 75-acre parcel at the Cascade Industrial Center. The rendering depicts the proposed project at 4620 172nd Street in Arlington from a northwest perspective.
1,000 jobs: Amazon to open distribution center in Arlington

The company is the tenant behind Project Roxy, a $355 million building at the Cascade Industrial Center.

FILE - In this Oct. 1, 2020 file photo, traffic passes the Boeing airplane production plant, in Everett, Wash.  U.S. manufacturers expanded in March 2021 at the fastest pace in 37 years, a sign of strengthening demand as the pandemic wanes and government emergency aid flows through the economy.  (AP Photo/Elaine Thompson, file)
Boeing sees uptick in airplane orders as travel picks up

The company in April delivered 19 Maxes, three 737s for military use and seven larger widebody planes.

FILE- In this Sept. 30, 2020, file photo, a Boeing 737 Max jet, piloted by Federal Aviation Administration (FAA) chief Steve Dickson, prepares to land at Boeing Field following a test flight in Seattle. Boeing says it has informed 16 of its customers that they should address a possible electrical issue in certain 737 Max aircraft before using them further. Boeing said Friday, April 9, 2021, that the recommendation was made “to allow for verification that a sufficient ground path exists for a component of the electrical power system.” (AP Photo/Elaine Thompson, File)
Boeing: possible electrical issue in some 737 Max aircraft

The company said that the new problem was unrelated to the flight-control system.

The 214-foot tall cranes work to unload their first cargo shipments at South Terminal at the Port of Everett on Thursday, April 8, 2021 in Everett, Wa. (Olivia Vanni / The Herald)
Renovated Port of Everett terminal gets first cargo customer

The 655-foot Westwood Columbia is the first ship to call at the newly upgraded South Terminal dock.

Edmonds grocery store workers may soon earn hazard pay

Some employers are required to increase wages by $4 an hour, the city council voted Tuesday.

Aerospace supplier with Everett site files for bankruptcy

Wichita-based TECT Aerospace filed for Chapter 11 and plans to sell an Everett manufacturing facility.

Washington's Lottery ticket display. (Andrea Brown / The Herald)
Want to get lucky? Washington’s Lottery lists Top 10 stores

One of the luckiest retailers in the state was a Safeway in Everett, as measured by $1,000-plus winners.

What local firms are doing to promote diversity and equity

Here’s how some of Snohomish County’s biggest companies and organizations say they are making a difference.

Garry Clark, the new CEO of Economic Alliance Snohomish County (Kevin Clark / The Herald)
At a tough time, a new CEO leads local economic development

Garry Clark has taken the helm at Economic Alliance Snohomish County, where job one is pandemic recovery.

Kathy Coffey (left) and Courtney Wooten
Leadership Snohomish County offers racial equity conference

The fifth annual day-long Step Up: Moving Racial Equity Forward will be held online on April 30.

Boeing President Ron Woodard, fifth from left, breaks ground with Boeing officials to make way for the Boeing Commercial Airplane Group Headquarters Office Building at the Longacres Park site in Renton Wash. Wednesday, May 14, 1997. (AP Photo/Loren Callahan)
For sale: Boeing’s Commercial Airplanes headquarters in Renton

A large warehouse on the Bomarc property in Everett also is for sale.